Kane Biotech, Inc. FDA Approvals

0 new drug approvals and 3 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
revyve® Antimicrobial Skin and Wound Cleanser510(k)Jan 8, 2026	—	510(k)Substantially Equivalent (Traditional)	Jan 8, 2026
coactiv+ Antimicrobial Wound Gel510(k)Jul 19, 2024	—	510(k)Substantially Equivalent (Special)	Jul 19, 2024
coactiv+ Antimicrobial Wound Gel510(k)May 24, 2023	—	510(k)Substantially Equivalent (Traditional)	May 24, 2023